The Association of Manufacturers of Pharmaceuticals of the Republic of Armenia (ArPharMa) is inviting you to participate in the virtual event that is unique for Russian speaking markets – Eurasian Virtual Pharmaceutical Summit that will take place on Advantix Pharma Virtual Platform on 14-21 October 2020.

The event will cover regulatory and commercial issues in the development of pharmaceutical markets in 13 countries, will attract 60+ speakers from regulatory authorities and leading pharmaceutical production and distribution companies and pharmacy chains and will attract 300+ participants.

Eurasian Virtual Pharmaceutical Summit programme will include presentations, discussions, round tables with regulators, one-to-one meetings with top managers of pharmaceutical production and distributions companies and pharmacy chains and many other formats.

The topics of the programme include:

  • Challenges for healthcare systems in Eurasian countries during the world pandemic COVID-19: what changes required?
  • Transition to mandatory registration of pharmaceutical drugs according to EAEU common rules: what changes were caused by COVID-19 and further plans for programme implementation
  • GMP inspections during world pandemic
  • Pharmaceutical drugs labelling in the EAEU
  • Trends in the development of commercial segment of pharmaceutical markets in Eurasia in 2020
  • Sales of pharmaceutical drugs in Eurasian countries in the first 9 months of 2020: results and forecast. Growth drivers and outsiders

Top speakers have already confirmed their participation in the summit:

  • Galiya Dzholdibaeva, Director, Business Development Department, Eurasian Economic Commission
  • Djanyl Djusupova, Technical Regulation and Accreditation Department, Eurasian Economic Commission
  • Dmitry Rozhdestvenskiy, Head of the Division for Coordination of Pharmaceutical Drugs and Medical Devices Circulation, Department of Technical Regulation and Accreditation, Eurasian Economic Commission
  • Beibut Essenbayev, Director of the Department of Healthcare Digitalization, Ministry of Healthcare of the Republic of Kazakhstan
  • Mkrtych Shakaryan, Head of Good Pharmaceutical Practice Department, Scientific Centre of Drug and Medical Technology Expertise after Academician E. Gabrielyan
  • Dmitry Schourov, Global Commercial Operations Lead France, Pfizer
  • Vitaly Bystryukov, Head of Business Unit General Medicine for Central Asia and Belarus, Chairman of the Board, Kazakhstan, Sanofi
  • Lidiya Klyuchareva, Head of CIS Country Group, Bayer Consumer Health
  • Roger Elia, General Manager, CIS, Merck
  • Alla Sorokoletova, Director of Medical and Regulatory Affairs, PV, QA Ukraine & CIS, Global Medical Affairs, Acino
  • Arminas Macevicius, Regional Director, Stada CIS
  • Anna Lakhtanova, Head of Regulatory Department, Novartis
  • Luvsan Erdenechimeg, CEO, Monos Pharma Trade (Mongolia)

The summit programme is attached. Association members have an opportunity to register with 15% discount, please use a VIP code ARPHARMA15 when register on the website.

Contacts: +7 495 2411405; email: